Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset

Tamashiro, Mirian S; Aikawa, Nadia Emi; Campos, Lucia Maria A; Cristofani, Lilian Maria; Odone-Filho, Vicente; Silva, Clovis A.
Clinics ; 66(10): 1665-1669, 2011. graf, tab
Artículo en Inglés | LILACS | ID: lil-601897

Documentos relacionados

  1. Inflammatory Biomarkers Can Differentiate Acute Lymphoblastic Leukemia with Arthropathy from Juvenile Idiopathic Arthritis Better Than Standard Blood Tests.
  2. [Recommendations of diagnosis and treatment of juvenile idiopathic arthritis in China].
  3. Mind the Gap: A Longitudinal Analysis of the Experiences of Adolescents and Parents in a Rheumatology Transition Clinic.
  4. What is the diagnostic yield of bone marrow aspiration to exclude leukaemia prior to systemic treatment in juvenile idiopathic arthritis?
  5. Disease activity assessment for juvenile idiopathic arthritis in transitional care.
  6. Early detection of high disease activity in juvenile idiopathic arthritis by sequential monitoring of patients' health-related quality of life scores.
  7. Performance of recent PRINTO criteria versus current ILAR criteria for systemic juvenile idiopathic arthritis: A single-centre experience.
  8. A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis.
  9. Type I interferon signature as a possible new marker for stratification of patients with juvenile idiopathic arthritis.
  10. Fifteen-minute guide to managing oligoarticular juvenile idiopathic arthritis.